{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:52:13Z","timestamp":1790052733921,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1124\/jpet.114.221341","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T03:11:32Z","timestamp":1430277092000},"page":"2-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["DSR-71167, a Novel Mineralocorticoid Receptor Antagonist with Carbonic Anhydrase Inhibitory Activity, Separates Urinary Sodium Excretion and Serum Potassium Elevation in Rats"],"prefix":"10.1016","volume":"354","author":[{"given":"Tetsuro","family":"Nariai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kawane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.221341_bib1","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"key":"10.1124\/jpet.114.221341_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.vascn.2008.01.002","article-title":"Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats","volume":"57","author":"Brandish","year":"2008","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.114.221341_bib3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1152\/jappl.1990.69.4.1397","article-title":"Body water and electrolyte responses to acetazolamide in humans","volume":"69","author":"Brechue","year":"1990","journal-title":"J Appl Physiol (1985)"},{"key":"10.1124\/jpet.114.221341_bib4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/qjmed\/hcs106","article-title":"Hyperkalaemia in the age of aldosterone antagonism","volume":"105","author":"Chapagain","year":"2012","journal-title":"QJM"},{"key":"10.1124\/jpet.114.221341_bib5","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1124\/jpet.114.221341_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.2011.1967","article-title":"Serum potassium levels and mortality in acute myocardial infarction","volume":"307","author":"Goyal","year":"2012","journal-title":"JAMA"},{"key":"10.1124\/jpet.114.221341_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000016027","article-title":"The dose-response relationship of acetazolamide on the cerebral blood flow in normal subjects","volume":"10","author":"Grossmann","year":"2000","journal-title":"Cerebrovasc Dis"},{"key":"10.1124\/jpet.114.221341_bib8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/archinte.1985.00360100075012","article-title":"Significant metabolic acidosis induced by acetazolamide. Not a rare complication","volume":"145","author":"Heller","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1124\/jpet.114.221341_bib9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.114.221341_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0161-6420(81)35041-6","article-title":"Acetazolamide and urolithiasis","volume":"88","author":"Kass","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1124\/jpet.114.221341_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade","volume":"30","author":"Khosla","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1124\/jpet.114.221341_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FJC.0000000000000091","article-title":"Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury","volume":"64","author":"Kolkhof","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.114.221341_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejim.2013.11.007","article-title":"Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review","volume":"25","author":"Mavrakanas","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1124\/jpet.114.221341_bib14","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1021\/jm100505n","article-title":"Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy","volume":"53","author":"Meyers","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.114.221341_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10157-008-0034-9","article-title":"Aldosterone and glomerular podocyte injury","volume":"12","author":"Nagase","year":"2008","journal-title":"Clin Exp Nephrol"},{"key":"10.1124\/jpet.114.221341_bib16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1248\/bpb.19.940","article-title":"Effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), an adenosine A1-receptor antagonist, on urinary excretions of various electrolytes in rats","volume":"19","author":"Nagashima","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/jpet.114.221341_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1254\/jphs.10285FP","article-title":"SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity","volume":"115","author":"Nariai","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.114.221341_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000335559","article-title":"Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone\/salt-treated rats","volume":"89","author":"Nariai","year":"2012","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.114.221341_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/FJC.0b013e3182495543","article-title":"SM-368229, a novel promising mineralocorticoid receptor antagonist, shows antihypertensive efficacy with minimal effect on serum potassium level in rats","volume":"59","author":"Nariai","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.114.221341_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.08R12FM","article-title":"Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers","volume":"109","author":"Nishiyama","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.114.221341_bib21","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","article-title":"Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial","volume":"34","author":"Pitt","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.114.221341_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.221341_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.221341_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/pgmj.2008.072058","article-title":"Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism","volume":"86","author":"Poggio","year":"2010","journal-title":"Postgrad Med J"},{"key":"10.1124\/jpet.114.221341_bib25","first-page":"213","article-title":"The inhibitory effect of diuretics on carbonic anhydrases","volume":"105","author":"Puscas","year":"1999","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1124\/jpet.114.221341_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1124\/jpet.114.221341_bib27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrneph.2012.217","article-title":"Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy","volume":"8","author":"Roscioni","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/jpet.114.221341_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrcardio.2009.244","article-title":"Heart failure: aldosterone antagonists are underused by clinicians","volume":"7","author":"Samuel","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1124\/jpet.114.221341_bib29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","article-title":"Effects of aldosterone on the vasculature","volume":"47","author":"Schiffrin","year":"2006","journal-title":"Hypertension"},{"key":"10.1124\/jpet.114.221341_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","article-title":"Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1","volume":"49","author":"Shibata","year":"2007","journal-title":"Hypertension"},{"key":"10.1124\/jpet.114.221341_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.114.221341_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11906-014-0467-3","article-title":"New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases","volume":"16","author":"Swenson","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"10.1124\/jpet.114.221341_bib33","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1210\/jc.2003-030490","article-title":"50th anniversary of aldosterone","volume":"88","author":"Williams","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.114.221341_bib34","first-page":"E883","article-title":"The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis","volume":"271","author":"Young","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.114.221341_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.221341_bib36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/10641963.2011.566956","article-title":"Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension","volume":"33","author":"Zhou","year":"2011","journal-title":"Clin Exp Hypertens"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524190556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524190556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.221341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:00:28Z","timestamp":1739988028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524190556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0022356524190556"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.221341","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DSR-71167, a Novel Mineralocorticoid Receptor Antagonist with Carbonic Anhydrase Inhibitory Activity, Separates Urinary Sodium Excretion and Serum Potassium Elevation in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.221341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}